MTCT: MRI, NMR detect early cancer treatment response

Links shared publicly online about this topic.

  • 1,593
    total visits

MTCT: MRI, NMR detect early cancer treatment response

healthimaging.com

BOSTON--Novel targeted cancer therapies could benefit from nuclear MR (NMR) and spectroscopy imaging to obtain an early indication of drug efficacy and guide personalized medicine, according to a presentation Tuesday at the Molecular Targets and Cancer Therapeutics (MTCT) conference.

View full resource at healthimaging.com

Tags: Cancer, Drug, Imaging Tests, Magnetic Resonance Imaging, Personalized Medicine, Nuclear, Radiology

  • Share

Most Recently Shared on November 18, 2009 at 3:13 pm By:

HealthImaging Health Imaging & IT

Conference: MRI, NMR detect early cancer treatment response http://tinyurl.com/ykhyqpz #radiology #imaging

2 years ago...

Advertisement